| abstract |
The present invention belongs to the field of medicine, and specifically relates to the aminoalcohol derivatives shown in the following formula I, their pharmaceutically acceptable salts, solvates, polymorphs or prodrugs. In addition, it also relates to a pharmaceutical composition comprising the above-mentioned substances, and the preparation of said substances for the prevention and treatment of immune inflammatory diseases or diseases or conditions related to immune activity such as multiple sclerosis, ALS, CIDP, systemic erythema Use in lupus, rheumatoid arthritis, ulcerative colitis, psoriasis, polymyositis, etc. |